Riociguat - Isotope Labelled Standards
References
FAQ's
References
- Alonso-Alija, Cristina; Bischoff, Erwin; Muenter, Klaus; Stasch, Johannes-Peter; Stahl, Elke; Weigand, Stefan; Feurer, Achim, Carbamate-Substituted Pyrazolopyridines, Bayer Aktiengesellschaft, Germany, EP1506193B1, June 21, 2006
- Gorumutchu, Giri Prasad; Ratnakaram, Venkata Nadh; Malladi, Sireesha, Determination of riociguat by oxidative coupling using visible spectrophotometry, Oriental Journal of Chemistry, Volume: 35, Issue: Spec.Iss.1, Pages: 48-53, 2019
Frequently Asked Questions
Why is it vital to control Riociguat impurities?
Controlling Riociguat impurities is essential for drug safety, quality, and efficacy.
How are Riociguat impurities characterized?
Various analytical techniques identify and characterize impurities. Impurities are properly quantified using reference standards and verified analytical procedures.
Can Riociguat impurities be minimized?
Various strategies are applied to control and minimize impurities during synthesis. It includes employing high-quality starting materials, following proper purification procedures, and performing quality control testing.
What are the temperature conditions required to store Riociguat impurities?
Riociguat impurities should be stored at a controlled room temperature between 2-8°C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.